Blood pressure management after endovascular thrombectomy: Insights of recent randomized controlled trials
CNS Neuroscience & Therapeutics · 2024-08 · 30 (8)
DOI: 10.1111/cns.14907 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 08.08.2024. Verfasst von Xiao Dong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Thrombectomy, Endovascular Procedures, Blood Pressure. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Science Foundation for Distinguished Young Scholars, Beijing Physician Scientist Training Project.
Abstract (Originalsprache)
Background
The ideal blood pressure (BP) target in patients who undergo endovascular thrombectomy (EVT) with successful reperfusion is uncertain. Observational studies show that elevated BP during this period is associated with a higher risk of intracranial hemorrhage (ICH) and worse clinical outcomes. Several randomized controlled trials (RCTs) have explored whether intensive BP lowering improves clinical outcomes in these patients.
Aims
This review aims to summarize the recent RCTs that compare intensive and conventional BP management strategies following EVT and discuss the innovative directions to improve.
Result
The recently published RCTs failed to demonstrate the benefit of intensive BP control on the functional outcome and decreasing the risk of ICH. The complex mechanism in cerebral blood flow regulation and the inappropriate BP range chosen in RCTs may be the reasons behind the inconsistent results between observational studies and RCTs. Individualized BP management, reducing BP variability, and multi‐stage BP management should be paid more attention in future exploration.
Conclusion
Intensive BP target did not improve clinical outcomes after successful EVT as compared with a conventional BP target. Further research is required to identify the optimal BP management strategy after reperfusion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
- Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Xunming Ji, Chuanjie Wu
Förderung
- National Natural Science Foundation of China
- Beijing Science Foundation for Distinguished Young Scholars
- Beijing Physician Scientist Training Project
Zitieren
APA
Dong, X., Liu, Y., Chu, X., Yu, E., Jia, X., Ji, X., & Wu, C. (2024). Blood pressure management after endovascular thrombectomy: Insights of recent randomized controlled trials. CNS Neuroscience & Therapeutics, 30(8). https://doi.org/10.1111/cns.14907
Vancouver
Dong X, Liu Y, Chu X, Yu E, Jia X, Ji X, et al. Blood pressure management after endovascular thrombectomy: Insights of recent randomized controlled trials. CNS Neuroscience & Therapeutics. 2024;30(8). doi:10.1111/cns.14907
BibTeX
@article{Dong2024,
author = {Dong, Xiao and Liu, Yuanyuan and Chu, Xuehong and Yu, Erlan and Jia, Xiaole and Ji, Xunming and Wu, Chuanjie},
title = {Blood pressure management after endovascular thrombectomy: Insights of recent randomized controlled trials},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
volume = {30},
number = {8},
doi = {10.1111/cns.14907}
}
EUVIMED